Picard Medical, Inc. (PMI) company profile
Close on Nov 17, 2026Market cap $16.16MP/E –Yield –
About Picard Medical
Surgical & Medical Instruments & Apparatus, SIC 3841
Picard Medical, Inc., operating primarily through its subsidiary SynCardia Systems, LLC, is a medical technology company specializing in mechanical circulatory support. The company manufactures and commercializes total artificial heart systems designed to replace the function of failing ventricles and valves in patients with end-stage biventricular heart failure. Its core product offering includes the 50cc and 70cc artificial heart implants paired with external pneumatic power systems: the mobile Companion 2 Driver for clinical inpatient stabilization and the lightweight Freedom Driver for outpatient home care. These devices serve primarily as a bridge to heart transplantation for hospitals, cardiac transplant centers, and surgeons treating critically ill patients.
The business operates internationally, with more than 2,100 artificial hearts implanted across 27 countries. Commercial availability centers on the United States and Canada, supported by entities and activities in Australia, China, and Germany. SynCardia maintains its operational headquarters in Tucson, Arizona.
Summary of the business section of Picard Medical's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Picard Medical, Inc.
- Founded
- 2021
- Headquarters
- Tucson, AZ
- Address
- 1992 E. Silverlake Rd. 85713
- Phone
- (520) 308-0796
- Website
- picardmedical.com
- Employees
- 75, Dec 31, 2025
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- MaloneBailey, LLP, Houston, Texas
Stock & identifiers
- Ticker
- PMI
- Exchange
- NYSE
- IPO date
- Sep 2, 2025
- Shares outstanding
- 2M, Aug 18, 2026
- Public float
- $130.82M, Sep 2, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Stock splits
- 1-for-50 reverse, Aug 3, 2026
- SEC CIK
- 2030617
- CUSIP
- 71953R108
- ISIN
- US71953R1086
- FIGI
- BBG000TR9Y22
- Share class FIGI
- BBG001T9HQK8
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Patrick Nj Schnegelsberg | Chief Executive Officer, Director | – |
| Matt Schuster | Chief Operating Officer | – |
| Bernard Skaggs | Chief Financial Officer | – |
| George Tiancheng Ye | Director | – |
| Richard Fang | Director | – |
| Van Sam | Director | – |
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Total | vs. prior year |
|---|---|---|---|
| Patrick NJ Schnegelsberg Former Chief Executive Officer | $400.00K | $400.00K | -76% |
| Bernard Skaggs Former Chief Financial Officer | $200.00K | $200.00K | -58% |
| Matt Schuster Chief Operating Officer | $220.00K | $220.00K | -58% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- Sep 2, 2025
- Offer price
- $4.00
- Securities offered
- 4,250,000
- Gross proceeds
- $17.00M
- Exchange
- NYSE
- First trading day
- Sep 2, 2025
- First-day close
- $5.14+28.5%
- Lock-up ends (est.)
- Mar 1, 2026
“The initial public offering price is $4.00 per share.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Aug 17, 2026 | Late filing | Notification of late filing |
| Jul 27, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| May 21, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| May 11, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Sep 2, 2025 | IPO | Initial public offering priced (424B4 prospectus) |
| Aug 11, 2025 | Listing | Registration of securities on an exchange (Form 8-A) |
See a number that looks wrong?